Reliability and Validity
In Vitro Drug Release Testing: Overview, Development and Validation
Self-Efficacy
Predicting Molecular Geometry
Sustainable Development
Prediction Intervals
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 2, 2026

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
Cecilia Karlsson1, Peter J Greasley2, David Gustafsson2
1Cardiovascular, Renal and Metabolism Translational Medicine Unit, Early Clinical Development, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden (C.K., P.J.G.); Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden (C.K.); Emeriti Pharma, AZ Bioventure Hub, Gothenburg, Sweden (D.G.); and KW Translational Medicine AB, Västra Frölunda, Sweden (K.W.) cecilia.karlsson@astrazeneca.com.
A new human target validation (HTV) system helps select effective drug targets early. This strategy predicts clinical efficacy, reducing late-stage failures and improving drug development success rates.
08:26Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Published on: June 14, 2018
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: